miR-155 miR-143在早发性卵巢功能不全患者中的表达及对成功妊娠的预测作用

doi:10.3969/j.issn.1006-6233.2023.04.016

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1719 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To analyze the expression of microRNA (miR)-155 and miR-143 in patients with premature ovarian insufficiency (POF), and to explore their predictive effect on successful pregnancy. Methods: A total of 172 patients with POF in our hospital from June 2020 to December 2021 were selected as the research objects, and 86 healthy people without POF during the same period were selected as the control. The expressions of miR-155 and miR-143 were compared between POF patients and non-POF healthy subjects, and the pregnancy was counted. Logistic regression was used to analyze the influencing factors of successful pregnancy in POF patients. The value of successful pregnancy in patients was analyzed with POF assessed by miR-155 and miR-143 by subject operating characteristic curve (ROC), decision curves were plotted to analyze the benefit of successful pregnancy in patients with POF assessed by miR-155 and miR-143, and the rate of successful pregnancy in patients with POF was compared with different expression of miR-155 and miR-143. Results: Patients with POF had lower miR-155 expression levels and higher miR-143 expression levels than healthy subjects with non-POF (P<0.05). There were 79 successful pregnancies and 93 non-pregnant cases in 172 POF patients; compared with non-pregnant POF patients, those with successful pregnancies had higher basal follicle counts, shorter duration of infertility, younger female age, younger male age, higher expression levels of anti-müllerian hormone and miR-155, and lower expression levels of miR-143 (P<0.05). Basal follicle count of 2-4 and high miR-155 expression were independent protective factors for pregnancy failure in POF patients, and low miR-143 expression was an independent risk factor for pregnancy failure in POF patients (P<0.05). The AUC value of the combined miR-155 and miR-143 assay to assess successful pregnancy in patients with POF was 0.812 (95% CI: 0.746 to 0.867), which was higher than the AUC values of miR-155 (χ²=2.625, P=0.009) and miR-143 (χ²=2.973, P=0.003) alone. Decision curve analysis showed that the net benefit of the combined miR-155 and miR-143 test in assessing successful pregnancy in POF patients was higher than that of the test alone when the risk threshold was 0.10 to 0.63. Decision curve analysis showed that the net benefit of the combined miR-155 and miR-143 test in assessing successful pregnancy in POF patients was higher than that of the test alone when the risk threshold was 0.10 to 0.63. miR-155+/miR-143- had a significantly higher rate of successful pregnancy than miR-155+/miR-143+, miR 155-/miR-143- and miR-155-/miR-143+ (P<0.05). Conclusion: POF patients with low miR-155 expression and high miR-143 expression, both of which have a direct impact on the success of pregnancy in POF patients. miR-155 high expression and miR-143 low expression have a higher success rate of pregnancy in POF patients, and the detection of miR-155 and miR-143 can predict pregnancy, which has certain clinical application value.

Key words： Premature ovarian insufficiency miR-155 miR-143 Pregnancy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HAO Dongmei
	YU Yuexin
	ZHAO Yingying

Cite this article:

HAO Dongmei,YU Yuexin,ZHAO Yingying. Expression of miR-155 and miR-143 in Patients with Premature Ovarian Insufficiency and Their Predictive Valne on Successful Pregnancy[J]. HeBei Med, 2023, 29(4): 605-612.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2023.04.016 OR http://www.hbyxzzs.cn/EN/Y2023/V29/I4/605

[1] Silven H,Savukoski SM,Pesonen P,et al.Incidence and familial risk of premature ovarian insufficiency in the finnish female population[J].Hum Reprod,2022,37(5):1030-1036.
[2] Liu T,Liu Y,Huang Y,et al.miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells[J].Free Radic Biol Med,2019,141(1):383-392.
[3] Devos M,Grosbois J,Demeestere I.Interaction between PI3K/AKT and Hippo pathways during in vitro follicular activation and response to fragmentation and chemotherapy exposure using a mouse immature ovary model[J].Biol Reprod,2020,102(3):717-729.
[4] American College of Obstetricians and Gynecologists.Committee opinion no.605:primary ovarian insufficiency in adolescents and young women[J].Obstet Gynecol,2014,124(1):193-197.
[5] 王华斌,李永文,丁勇利.维生素E联合激素补充疗法对卵巢早衰患者内分泌及生育功能的影响[J].中国煤炭工业医学杂志,2021,24(2):204-208.
[6] Tokumaru Y,Asaoka M,Oshi M,et al.High expression of microRNA-143 is associated with favorable tumor immune microenvironment and better survival in estrogen receptor positive breast cancer[J].Int Mol Sci,2020,21(9):3213.
[7] Arena A,Iyer AM,Milenkovic I,et al.Developmental expression and dysregulation of miR-146a and miR-155 in down's syndrome and mouse models of down's syndrome and alzheimer's disease[J].Curr Alzheimer Res,2017,14(12):1305-1317.
[8] Thorne L,Lu J,Chaudhry Y,et al.miR-155 induction is a marker of murine norovirus infection but does not contribute to control of replication in vivo[J].Wellcome Open Res,2018,3(1):42.
[9] 王海丹,郭红玉,马蔚蓉,等.自身免疫型卵巢早衰模型的研究[J].中国实验动物学报,2021,29(5):563-569.
[10] Grynberg M,Jacquesson L,Sifer C.In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency[J].Fertil Steril,2020,114(4):848-853.
[11] Liu Y,Zhao X,Li J,et al.MiR-155 inhibits TP53INP1 expression leading to enhanced glycolysis of psoriatic mesenchymal stem cells[J].Dermatol Sci,2022,105(3):142-151.
[12] Tamgue O,Gcanga L,Ozturk M,et al.Differential targeting of c-Maf,Bach-1,and Elmo-1 by microRNA-143 and microRNA-365 promotes the intracellular growth of mycobacterium tuberculosis in alternatively IL-4/IL-13 activated macrophages[J].Front Immunol,2019,10(1):421.
[13] 高小博,姚楠,郑盼盼,等.miR-143在卵泡刺激素介导的卵巢颗粒细胞孕酮生成中的作用[J].生殖医学杂志,2019,28(6):684-688.
[14] Wen JF,Jiang YQ,Li C,et al.LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2[J].Cancer Biomark,2020,28(2):231-246.
[15] Zhang T,Zhang Z,Li F,et al.miR-143 regulates memory T cell differentiation by reprogramming T cell metabolism[J].Immunol,2018,201(7):2165-2175.